Quantcast
Last updated on April 23, 2014 at 1:22 EDT

Latest Sacral nerve stimulation Stories

2012-03-05 10:00:00

IncoStress, now sold in Canada by Bescot Healthcare Canada, is a device, worn like a tampon, that can help many women who suffer in silence with the potentially devastating disability of Urinary Stress Incontinence. Toronto, Ontario, Canada (PRWEB) March 05, 2012 IncoStress, now available in Canada through Bescot Healthcare, could help end the suffering for the many women who live with Urinary Stress Incontinence - the involuntary loss of urine when, for example, coughing, sneezing,...

2012-02-15 15:02:00

MINNEAPOLIS, Feb. 15, 2012 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ:UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced the first enrollment of patients in the CONFIDeNT clinical study in the United Kingdom. This large multi-center, placebo-controlled study will enroll over 200 patients in up to 20 centers across the UK. Using Uroplasty's minimally-invasive Urgent® PC Neuromodulation System,...

2011-11-09 06:00:00

MINNEAPOLIS, Nov., 9, 2011 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced the issuance of United States Patent No. 8,046,082 covering the stimulator used in the Urgent® PC Neuromodulation System. The Urgent PC Neuromodulation System is an office-based, non-surgical system, used to treat overactive bladder syndrome (OAB) and the...

2011-10-14 06:11:00

CAMPBELL, Calif., Oct. 14, 2011 /PRNewswire/ -- EMKinetics, Inc. announced today initiation of the TranStim(TM) Transdermal Neuromodulation System pivotal trial for patients suffering from urge incontinence and overactive bladder. The 120-person trial will be conducted at 10-15 US centers. Submission for CE mark and 510(k) clearance will follow the completion of the study. EMKinetics' TranStim therapy builds on the body of evidence that posterior tibial nerve stimulation (PTNS) can...

2011-08-15 05:30:00

MINNETONKA, Minn., Aug. 15, 2011 /PRNewswire/ -- Uroplasty, Inc. (Nasdaq: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that the results of two clinical studies using Uroplasty's Urgent® PC Neuromodulation System are scheduled to be presented at the International Continence Society meeting, August 29-September 2, 2011 in Glasgow, Scotland. "These data from on-going...

2011-07-18 15:58:28

Northwestern Memorial is among the first medical centers to offer sacral nerve stimulation A new procedure is now available for the treatment of chronic bowel incontinence, a disorder impacting the lives of more than 18 million Americans. The treatment, called InterStim® Therapy is a minimally invasive procedure which uses electrical impulses to stimulate the sacral nerve and improve muscle function. It is one of the only effective long-term treatments for bowel incontinence...

2011-07-18 11:59:00

Northwestern Memorial is among the first medical centers to offer sacral nerve stimulation CHICAGO, July 18, 2011 /PRNewswire-USNewswire/ -- A new procedure is now available for the treatment of chronic bowel incontinence, a disorder impacting the lives of more than 18 million Americans. The treatment, called InterStim® Therapy is a minimally invasive procedure which uses electrical impulses to stimulate the sacral nerve and improve muscle function. It is one of the...

2011-05-31 05:30:00

MINNEAPOLIS, May 31, 2011 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), announced today that the United Kingdom's National Institute for Health and Clinical Excellence (NICE) issued guidance on percutaneous tibial nerve stimulation (PTNS) for the treatment of faecal incontinence. In October 2010, NICE issued similar guidance on PTNS treatment for overactive bladder. "This NICE guidance should encourage physicians in the UK and Europe to use our Urgent® PC...

2011-04-25 05:55:00

MINNETONKA, Minn., April 25, 2011 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that the results of clinical studies using Uroplasty's Urgent® PC Neuromodulation System and Macroplastique® urethral bulking agent products are scheduled to be presented at three upcoming professional meetings. The meetings include...

2011-01-12 14:09:34

For men with incontinence for at least one year following radical prostatectomy, participation in a behavioral training program that included pelvic floor muscle training, bladder control strategies and fluid management, resulted in a significant reduction in the number of incontinence episodes, according to a study in the January 12 issue of JAMA. The researchers also found that the addition of biofeedback and pelvic floor electrical stimulation provided no additional benefit. "Men in the...